Defective myogenic response of retinal vessels is associated with accelerated onset of retinopathy in type 1 diabetic individuals

Investigative Ophthalmology and Visual Science

Volumn 57, Issue 4, 2016, Pages 1523-1529

  Tecilazich, Francesco ^a   Feke, Gilbert T ^b   Mazzantini, Sara ^a   Sobrin, Lucia ^b   Lorenzi, Mara ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Accelerator; Biomarker; Laser doppler; Myogenic response; Retinal blood flow; Retinal circulation; Retinopathy; Type 1 diabetes

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; OPHTHALMODYNAMOMETRY; PERFUSION PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA BLOOD FLOW; RETINA BLOOD VESSEL; BLOOD FLOW; BLOOD FLOW VELOCITY; BLOOD PRESSURE; LASER DOPPLER FLOWMETRY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PERFUSION; RETINA ARTERY; VASCULAR SMOOTH MUSCLE; YOUNG ADULT;

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; PERFUSION; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; RETINAL ARTERY; YOUNG ADULT;

EID: 84962464669     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.15-18356     Document Type: Article

References (23)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329: 977-986.
2. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-412.
3. The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327-1334.
4. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care. 2014;37:S14-S80.
5. The ACCORD Study Group. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364:818-828.
6. Lorenzi M, Feke GT, Cagliero E, et al. Retinal haemodynamics in individuals with well-controlled type 1 diabetes. Diabetologia. 2008;51:361-364.
7. Lorenzi M, Feke GT, Pitler L, Berisha F, Kolodjaschna J, McMeel JW. Defective myogenic response to posture change in retinal vessels of well-controlled type 1 diabetic patients with no retinopathy. Invest Ophthalmol Vis Sci. 2010;51:6770-6775.
8. Hill MA, Meininger GA, Davis MJ, Laher I. Therapeutic potential of pharmacologically targeting arteriolar myogenic tone. Trends Pharmacol Sci. 2009;30:363-374.
9. Hammes HP, Kerner W, Hofer S, et al. Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients. Diabetologia. 2011;54:1977-1984.
10. Yoshida A, Feke GT, Mori F, et al. Reproducibility and clinical application of a newly developed stabilized retinal laser Doppler instrument. Am J Ophthalmol. 2003;135:356-361.
11. Tang J, Mohr S, Du YD, Kern TS. Non-uniform distribution of lesions and biochemical abnormalities within the retina of diabetic humans. Curr Eye Res. 2003;27:7-13.
12. Feke GT, Pasquale LR. Retinal blood flow response to posture change in glaucoma patients compared with healthy subjects. Ophthalmology. 2008;115:246-252.
13. Hague S, Hill DW. Postural changes in perfusion pressure and retinal arteriolar calibre. Br J Ophthalmol. 1988;72:253-257.
14. Kohner EM, Patel V, Rassam SM. Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes. 1995;44:603-607.
15. Schmetterer L, Wolzt M. Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia. 1999;42:387-405.
16. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 1995;44: 968-983.
17. Quigley M, Cohen S. A new pressure attenuation index to evaluate retinal circulation. A link to protective factors in diabetic retinopathy. Arch Ophthalmol. 1999;117:84-89.
18. Man RE, Sasongko MB, Sanmugasundram S, et al. Longer axial length is protective of diabetic retinopathy and macular edema. Ophthalmology. 2012;119:1754-1759.
19. Quigley M. Retinal capillary flow and diabetic retinopathy. Invest Ophthalmol Vis Sci. 2015;56:2001.
20. Frederiksen CA, Jeppesen P, Knudsen ST, Poulsen PL, Mogensen CE, Bek T. The blood pressure-induced diameter response of retinal arterioles decreases with increasing diabetic maculopathy. Graefes Arch Clin Exp Ophthalmol. 2006;244:1255-1261.
21. Schofield I, Malik R, Izzard A, Austin C, Heagerty A. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation. 2002;106:3037-3043.
22. Lasta M, Pemp B, Schmidl D, et al. Neurovascular dysfunction precedes neural dysfunction in the retina of patients with type 1 diabetes. Invest Ophthalmol Vis Sci. 2013;54:842-847.
23. Trick GL, Edwards P, Desai U, Berkowitz BA. Early supernormal retinal oxygenation response in patients with diabetes. Invest Ophthalmol Vis Sci. 2006;47:1612-1619